It should be noted that higher dosages of vitamin B12 may be necessary when treating this population
often considered for obesity treatment under new formularies | Generally covered under diabetes management plans | | Off-Label Use | Not used off-labelapproved for weight loss | Frequently used off-label for weight loss | Conclusion: Weighing Real Differences Between Zepbound and Mounjaro Neither Zepbound nor Mounjaro exists in a vacuumthey're both weekly injectable drugs rooted in tirzepatide, developed by Eli Lilly, and administered via similar pens
TRAILBLAZER-ALZ 4 (NCT05108922) is a phase 3, open-label, head-to-head comparison of amyloid clearance by either donanemab or aducanumab that began in November 2021 after the US FDA approval of aducanumab
However, it led to significant weight loss in diabetic patients
Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, et al